BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia
Yafeng Zhou(The University of Queensland), Wee Joo Chng(National University of Singapore)
Cited by 17
Related Papers
Enabling Technologies for Personalized and Precision Medicine
|Trends in biotechnology|2020|483
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
|The Lancet Oncology|2021|266
The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML
|Blood|2011|212
Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia
|Journal of Hematology & Oncology|2017|75